Funding Opportunities

NIH- Research Answers to NCI’s Provocative Questions – Group D (R01) – RFA-CA-13-022

due: 20-06-2014 Research NIH RFA-CA-13-022 Faculty required
List of PQs for this FOA: Group D Each application must address one and only one specific PQ from Group D, exactly as defined in this FOA. PQD1: (Retained from 2012) What molecular properties make some cancers curable with conventional chemotherapy? PQD2: (New for 2013) What features of standard-of-care therapies enhance or inhibit the efficacy of immunotherapy? PQD3: (New for 2013) Do tumors evolve common features that could act as new therapeutic targets when they metastasize to the same secondary site? PQD4: (New for 2013) What are the mechanistic bases for differences in cancer drug metabolism and toxicity at various stages of life?

NIH – Research Answers to NCI’s Provocative Questions- Group D (R21)- RFA-CA-13-023

due: 20-06-2014 Research NIH RFA-CA-13-023 Faculty required
List of PQs for this FOA: Group D Each application must address one and only one specific PQ from Group D, exactly as defined in this FOA. PQD1: (Retained from 2012) What molecular properties make some cancers curable with conventional chemotherapy? PQD2: (New for 2013) What features of standard-of-care therapies enhance or inhibit the efficacy of immunotherapy? PQD3: (New for 2013) Do tumors evolve common features that could act as new therapeutic targets when they metastasize to the same secondary site? PQD4: (New for 2013) What are the mechanistic bases for differences in cancer drug metabolism and toxicity at various stages of life?

NIH – Research Answers to NCI’s Provocative Questions – Group E (R01)- RFA-CA-13-024

due: 20-06-2014 Research NIH RFA-CA-13-024 Faculty required
Each application must address one and only one specific PQ from Group E, exactly as defined in this FOA. PQE1: (New for 2013) What strategies optimize adoption and sustainability of guideline concordant cancer treatments in community settings? PQE2: (New for 2013) What care delivery models can be developed to transition cancer patients effectively from active therapy to end of life care? PQE3: (New for 2013) What methods and approaches induce physicians and health systems to abandon ineffective interventions or discourage adoption of unproven interventions? PQE4: (New for 2013) What are the best methods to identify and stratify subgroups of patients with particular co-morbidities who will benefit from defined cancer therapies?

Industry/University Cooperative Research Centers Program (I/UCRC)

due: 27-06-2014 Research NSF NSF 13-594 Faculty required
The Industry/University Cooperative Research Centers (I/UCRC) program develops long-term partnerships among industry, academe, and government. The centers are catalyzed by a small investment from the National Science Foundation (NSF) and are primarily supported by industry center members, with NSF taking a supporting role in the development and evolution of the center. Each center is established to conduct research that is of interest to both the industry members and the center faculty. An I/UCRC contributes to the nation's research infrastructure base and enhances the intellectual capacity of the engineering and science workforce through the integration of research and education. As appropriate, an I/UCRC uses international collaborations to advance these goals within the global context.

Innovation Corps Sites Program (I-Corps Sites)

due: 27-06-2014 Research NSF NSF 14-547 Faculty required
The National Science Foundation (NSF) seeks to develop and nurture a national innovation ecosystem that builds upon research to guide the output of scientific discoveries closer to the development of technologies, products and processes that benefit society. In order to contribute to a national innovation ecosystem, NSF established the NSF Innovation Corps Sites Program (NSF I-Corps Sites). Sites are funded at academic institutions, having already existing innovation or entrepreneurial units, to enable them to: Nurture students and/or faculty who are engaged in projects having the potential to be transitioned into the marketplace. I-Corps Sites will provide infrastructure, advice, resources, networking opportunities, training and modest funding to enable groups to transition their work into the marketplace or into becoming I-Corps Team applicants (see NSF Innovation Corps Program, NSF 12-602). Develop formal, active, local innovation ecosystems that contribute to a larger, national network of mentors, researchers, entrepreneurs and investors. The purpose of an I-Corps Site is to nurture and support multiple, local teams to transition their ideas, devices, processes or other intellectual activities into the marketplace.